Social implications of recent advances in psychopharmacology.
D000342:Affective Symptoms / Q000188:drug therapy; D000639:Amitriptyline / Q000627:therapeutic use; D002908:Chronic Disease; D003863:Depression / Q000188:drug therapy*; D004565:Electroconvulsive Therapy; D006760:Hospitalization; D006778:Hospitals, Psychiatric; D006801:Humans; D007902:Length of Stay; D008605:Mental Health Services; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010640:Phenothiazines / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D013405:Suicide / Q000453:epidemiology; D006113:United Kingdom
D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D000639:Amitriptyline